Redox dyshomeostasis strategy for tumor therapy based on nanomaterials chemistry-Reference-Cited by-同舟云学术

Redox dyshomeostasis strategy for tumor therapy based on nanomaterials chemistry

Published:2022 Issue:8 Volume:13 Page:2202-2217
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Wu Yelin¹²^ORCID,Li Yanli³,Lv Guanglei²,Bu Wenbo¹²^ORCID

Affiliation:

1. Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tongji University, Tongji University Cancer Center, Tongji University School of Medicine, Shanghai, P. R. China

2. Department of Materials Science and State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, P. R. China

3. Key Laboratory of Molecular Target and Clinical Pharmacology & the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University Guangzhou, P. R. China

Abstract

This review summarizes the current progress of the redox dyshomeostasis (RDH) strategy for tumor therapy. This strategy makes tumor cells more sensitive to current therapy patterns through using nanomaterials to disrupt redox homeostasis.

Funder

China National Funds for Distinguished Young Scientists

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/SC/D1SC06315D

Reference107 articles.

1. Redox Homeostasis and Mitochondrial Dynamics

2. Mitochondrial ROS Signaling in Organismal Homeostasis